コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 s the localized interaction of PD-L1 and the beta4 integrin.
2 ls to resist ferroptosis in concert with the beta4 integrin.
3 ntial for its binding with the cytodomain of beta4 integrin.
4 th the upregulation of MMP-9 and cleavage of beta4 integrin.
5 atic MNNG-HOS cells have increased levels of beta4 integrin.
6 p63 was rescued by signalling downstream of beta4 integrin.
7 s, epitope-tagged PMP22 forms a complex with beta4 integrin.
8 e.g. hCLCA2, mCLCA5, mCLCA1, and bCLCA2) and beta4 integrin.
9 if within the extracellular I-like domain of beta4 integrin.
10 essed in endothelia, failed to interact with beta4 integrin.
11 elial cells, which express little endogenous beta4 integrin.
12 autoantibodies in OCP sera specific for the beta4 integrin.
13 y up-regulated genes, including survivin and beta4-integrin.
14 was positive, yet attenuated, for alpha6 and beta4 integrins.
15 uced the expression of hemidesmosomal alpha6/beta4-integrins.
18 epithelial cells upregulate and internalize beta4-integrin along with its matrix substrate, laminin.
19 bnormalities in the expression of the alpha6 beta4 integrin, an integral component of hemidesmosomes.
20 dc)-1 engaging the cytoplasmic domain of the beta4 integrin and coupling of the integrin to human epi
21 eviously uncharacterized interaction between beta4 integrin and ezrin, a membrane-cytoskeletal linker
22 portantly, the concomitant overexpression of beta4 integrin and FAK significantly correlates with mal
23 physical and functional interactions between beta4 integrin and FAK that influence breast cancer mali
25 a4 integrin, which, in turn, recruits FAK to beta4 integrin and leads to FAK activation and signaling
26 inflammation was delayed, and expression of beta4 integrin and p21 was reduced in lysates of constit
27 cular arrest of cancer cells via adhesion to beta4 integrin and promote early, intravascular, metasta
28 However, the amount of Rac1 associating with beta4 integrin and the activity of both Rac1 and cofilin
29 transfected constructs encoding the mutated beta4 integrins and a GFP-conjugated wild type beta4 int
30 e following levels: p < 0.001 for alpha6 and beta4 integrins and the beta3 chain of laminin 5; p < 0.
31 In these same cells, BPAG1e, the truncated beta4 integrin, and type XVII collagen (Col XVII), a tra
32 three signaling pathways (NF-kappaB, alpha6-beta4-integrin, and IL-1) as differentially upregulated
37 uring early stages of myelination, PMP22 and beta4 integrin are coexpressed at the cell surface and c
38 also a functional connection between CD9 and beta4 integrins, as evidenced by anti-CD9 antibody effec
39 es and JEB keratinocytes, induced to express beta4 integrin, assemble laminin-332 in linear tracks ov
41 keratinocytes also display reduced levels of beta4 integrins at the cell surface but increased total
44 odia, and directed migration are restored in beta4 integrin-deficient cells by inducing expression of
45 typical of confluent, stationary cells, and beta4 integrin dynamics are reduced in knockdown cells c
48 Our analysis revealed that manipulation of beta4 integrin expression and signaling impacted SPARC e
55 escribes a pro-metastatic EGFR/Src-dependent beta4 integrin/FAK complex that is involved in breast ca
57 tegrin expression by shRNA and disruption of beta4 integrin function by transfection of dominant-nega
58 ta4 integrins and a GFP-conjugated wild type beta4 integrin (GFP-beta4WT) into 804G cells, which asse
65 The corresponding CLCA-binding domain of the beta4 integrin is localized to the specific determining
68 The alpha6beta4 integrin (referred to as "beta4" integrin) is a receptor for laminins that promote
69 e gene encoding the hemidesmosome-associated beta4 integrin (ITGB4), and in the gene for the hemidesm
72 d a mutation within the I-like domain of the beta4 integrin, lying outside the SDL region (GFP-beta4V
73 ncreased proliferation (Ki-67) and adhesion (beta4 integrin) markers, and induced inflammatory cell i
74 ense mutation in the extracellular domain of beta4 integrin may affect ligand binding or dimerization
75 We report here that alphaE-catenin inhibits beta4 integrin-mediated activation of SRC tyrosine kinas
77 of either primary human keratinocytes (NHK), beta4 integrin-null human keratinocytes (beta4-), or tho
78 ve in keratinocytes exhibiting deficiency in beta4 integrin or knockdown of the plakin protein Bullou
83 , re-expression of alpha6 integrin increases beta4 integrin protein at the cell surface, which result
85 stiffness and composition is sensed through beta4 integrin, Rac1, and the PI3K pathway, and suggest
87 ic studies revealed the balance of beta1 and beta4 integrin signaling, hemidesmosome formation, and l
88 ng that the clustering of alpha6beta4 with a beta4 integrin-specific antibody promotes p53-dependent
89 -catenin involves negative regulation of the beta4 integrin-SRC signaling pathway and that SRC-mediat
90 h Sdc1 engages the cytoplasmic domain of the beta4 integrin subunit allowing HER2-dependent motility
92 provide evidence that the SDL segment of the beta4 integrin subunit is required for ligand binding an
94 n of the alpha2beta1 integrin, the alpha6 or beta4 integrin subunit was expressed in our Mm5MT model.
95 their ability to increase expression of the beta4 integrin subunit, a component of the alpha6beta4 i
97 of patients with MMP and OCP recognize only beta4 integrin subunit, and sera of OP patients recogniz
98 cicatricial pemphigoid (OCP) sera recognize beta4 integrin subunit, oral pemphigoid sera recognize a
100 he notion of close association of the alpha6 beta4 integrin subunits and further attest to the critic
101 ults in up-regulation of both the alpha6 and beta4 integrin subunits but no change in the alpha1, alp
102 rther investigate the role of the alpha6 and beta4 integrin subunits in mediating the phenotypic chan
106 generated point mutations within the SDL of beta4 integrin tagged with green fluorescent protein (GF
107 mammary tumors lacking functional beta1 and beta4 integrin through activation of NFkappaB, and overe
108 was also shown to colocalize with Rab27B and beta4 integrin to early adhesion initiation sites in spr
110 in ECS cells, where it interacts with alpha6/beta4 integrin to stimulate FAK and Src signaling, leadi
111 ction by interacting with and localizing the beta4 integrin to the rear enabling this integrin to sti
112 ative genes, 14-3-3sigma, S100P, S100A6, and beta4 integrin, to neoplastic cells in pancreatic tumors
114 an keratinocytes (beta4-), or those in which beta4 integrin was reexpressed (beta4+), were tracked du
115 unction by transfection of dominant-negative beta4 integrin was sufficient to revert this highly meta
117 y inducing expression of a truncated form of beta4 integrin, which lacks binding sites for BPAG1e and
118 ing triggers the tyrosine phosphorylation of beta4 integrin, which, in turn, recruits FAK to beta4 in